navan
/
Daily-Dose
mirror of https://github.com/navanchauhan/Daily-Dose.git
1
0
Fork 0
Code Issues Projects Releases Wiki Activity

Added daily report

This commit is contained in:
Navan Chauhan 2021-07-15 12:51:32 +00:00
parent e9887f34e3
commit d6d3bc5374
3 changed files with 675 additions and 2 deletions
Show Stats Download Patch File Download Diff File Expand all files Collapse all files

201
archive-covid-19/15 July, 2021.html Normal file
View File

@ -0,0 +1,201 @@
<!DOCTYPE html>
<html lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml"><head>
<meta charset="utf-8"/>
<meta content="pandoc" name="generator"/>
<meta content="width=device-width, initial-scale=1.0, user-scalable=yes" name="viewport"/>
<title>15 July, 2021</title>
<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
</style>
<title>Covid-19 Sentry</title><meta content="width=device-width, initial-scale=1.0" name="viewport"/><link href="styles/simple.css" rel="stylesheet"/><link href="../styles/simple.css" rel="stylesheet"/><link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet"/><script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script></head>
<body>
<h1 data-aos="fade-down" id="covid-19-sentry">Covid-19 Sentry</h1>
<h1 data-aos="fade-right" data-aos-anchor-placement="top-bottom" id="contents">Contents</h1>
<ul>
<li><a href="#from-preprints">From Preprints</a></li>
<li><a href="#from-clinical-trials">From Clinical Trials</a></li>
<li><a href="#from-pubmed">From PubMed</a></li>
<li><a href="#from-patent-search">From Patent Search</a></li>
</ul>
<h1 data-aos="fade-right" id="from-preprints">From Preprints</h1>
<ul>
<li><strong>The best-case heuristic: Relative optimism in a global health pandemic</strong> -
<div>
In the first wave of COVID-19, we examined how people evaluate personal risk in a global pandemic. Three experiments identified two kinds of relative optimism (N=2,300 Americans). Consistent with a best-case heuristic, participants made “realistic” predictions of infection risk that were closer to their own best-case scenario than to their worst-case scenario. Infection risk was also rated as lower for oneself than the average person, indicating unrealistic optimism. Both effects were successfully replicated in a high-powered replication (nationally- representative). More generally, infection risk predictions were positively correlated with emotional distress, pro- social intentions, and support of public-health lockdown policies. Although a bipartisan majority supported lockdown, right-leaning conservatives made lower risk predictions and were less supportive than left-leaning liberals. Resistance to early lockdown was also associated with the belief in national superiority. Finally, the best-case heuristic generalized to predicted waiting time for a COVID-19 vaccine and future relationship satisfaction, suggesting a broader pattern.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://psyarxiv.com/pcj4f/" target="_blank">The best-case heuristic: Relative optimism in a global health pandemic</a>
</div></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Building a Psychological Ground Truth Dataset with Empathy and Theory-of-Mind During the COVID-19 Pandemic</strong> -
<div>
As the mental health crisis deepens with the prolonged COVID-19 pandemic, there is an increasing need for understanding individuals’ emotional experiences. We have built a large-scale Korean text corpus with five self-labeled psychological ground-truths: empathy, loneliness, stress, personality, and emotions. We collected 19,025 documents of daily emotional experiences from 3,805 Korean residents from October to December 2020. We collected 42,128 sentences with different levels of theory-of-mind. Each sentence was annotated by trained psychology students and reviewed by experts. Participants varied in their ages from the early 20s to late 80s and had various social and economic statuses. The pandemic impacted the majority of daily lives, and participants often reported negative emotional experiences. We found the most frequent topics: responses to confirmed cases, health concerns of family members, anger towards people without masks, stress-relief strategies, change of the lifestyle, and preventive practices. We then trained the Word2Vec model to observe specific words that match each topic from the topic model. The current dataset will serve as benchmark data for large-scale and computational methods for identifying mental health levels based on text. This dataset is expected to be used and transformed in many creative ways to mitigate COVID-19-related mental health problems.
</div></li>
</ul>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://psyarxiv.com/mpn3w/" target="_blank">Building a Psychological Ground Truth Dataset with Empathy and Theory-of-Mind During the COVID-19 Pandemic</a>
</div>
<ul>
<li><strong>Problems and Needs Analysis of English for Tourism Industry: A Case of Hotel Staff in Phang Nga Province, Thailand</strong> -
<div>
Tourism is an important industry that has created a lot of income for many nations, including Thailand; therefore, it is essential to increase its potential as a more sustainable and successful industry, in particular to support a sustainable recovery of nations’ economies after a tough situation like Covid-19. The present study was carried out to investigate tourism staff’s problems and needs for using English at work and to explore their needs for improving English for their work. The participants were 200 hotel staff in Phang Nga Province, Thailand. Data were collected through a 5-point Likert scale questionnaire and a semi-structured interview. Quantitative and qualitative methods were employed for data analysis. The findings showed that in general, the hotel staff’s problem in using English at work was at a moderate level (M=2.76, S.D.=1.11). They had English writing problems the most. They found it very difficult to write letters or e-mails in English. Regarding their needs for using English, it was found that every English skill was rated at a high level (M=3.75, S.D.=1.11), and English speaking was the most necessary. The hotel staff reported that they had to speak English to welcome, greet and say good-bye to foreign guests. Pertaining to their needs for improving English, overall, the hotel staff needed to improve their English skills at a high level (M=3.85, S.D.=0.98). They highly needed to improve their English use in every aspect, especially English listening. Based on the interview information, English courses, handbooks or applications relating to English for hotels are truly needed for their English use improvement.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://osf.io/adk6e/" target="_blank">Problems and Needs Analysis of English for Tourism Industry: A Case of Hotel Staff in Phang Nga Province, Thailand</a>
</div></li>
<li><strong>Conversion rate to the secondary conformation state in the binding mode of SARS-CoV-2 spike protein to human ACE2 may predict infectivity efficacy of the underlying virus mutant</strong> -
<div>
Since its outbreak in 2019 SARS-CoV-2 has spread with high transmission efficiency across the world, putting health care as well as economic systems under pressure. During the course of the pandemic, the originally identified SARS- CoV-2 variant has been widely replaced by various mutant versions, which showed enhanced fitness due to increased infection and transmission rates. In order to find an explanation, why SARS-CoV-2 and its emerging mutated versions showed enhanced transfection efficiency as compared to SARS-CoV 2002, an improved binding affinity of the spike protein to human ACE has been proposed by crystal structure analysis and was identified in cell culture models. Kinetic analysis of the interaction of various spike protein constructs with the human ACE2 was considered to be best described by a Langmuir based 1:1 stoichiometric interaction. However, we demonstrate in this report that the SARS-CoV-2 spike protein interaction with ACE2 is best described by a two-step interaction, which is defined by an initial binding event followed by a slower secondary rate transition that enhances the stability of the complex by a factor of ~190 with an overall KD of 0.20 nM. In addition, we show that the secondary rate transition is not only present in SARS-CoV-2 wt but is also found in B.1.1.7 where its transition rate is five-fold increased.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.14.452313v1" target="_blank">Conversion rate to the secondary conformation state in the binding mode of SARS-CoV-2 spike protein to human ACE2 may predict infectivity efficacy of the underlying virus mutant</a>
</div></li>
<li><strong>Xeno-nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding</strong> -
<div>
The causative agent of COVID-19, SARS-CoV-2, gains access to cells through interactions of the receptor binding domain (RBD) on the viral S protein with angiotensin converting enzyme 2 (ACE2) on the surface of human host cells. Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was used to generate aptamers (nucleic acids selected for high binding affinity to a target) to the RBD made from 2’-fluoroarabinonucleic acid (FANA). The best selected ~ 79 nucleotide aptamers bound the RBD (Arg319-Phe541) and the larger S1 domain (Val16-Arg685) of the 1272 amino acid S protein with equilibrium dissociation constants (KD,app) of ~ 10-20 nM and a binding half-life for the RBD of 53 {+/-} 18 minutes. Aptamers inhibited the binding of the RBD to ACE2 in an ELISA assay. Inhibition, on a per weight basis, was similar to neutralizing antibodies that were specific for RBD. Aptamers demonstrated high specificity, binding with about 10-fold lower affinity to the related S1 domain from the original SARS virus, which also binds to ACE2. Overall, FANA aptamers show affinities comparable to previous DNA aptamers to RBD and S protein and directly block receptor interactions while using an alternative Xeno-nucleic acid (XNA) platform.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.452259v1" target="_blank">Xeno-nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding</a>
</div></li>
<li><strong>Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets</strong> -
<div>
Libraries composed of licensed drugs represent a vast repertoire of molecules modulating physiologic processes in humans, thus providing unique opportunities for discovery of host targeting antivirals. We interrogated the ReFRAME repurposing library with 12,993 molecules for broad-spectrum coronavirus antivirals and discovered 134 compounds inhibiting an alphacoronavirus, mapping to 59 molecular target categories. Dominant targets included the 5-hydroxytryptamine receptor and dopamine receptor and cyclin-dependent kinase inhibitors. Counter-screening with SARS- CoV-2 and validation in primary cells identified Phortress, an aryl hydrocarbon receptor (AHR) ligand, Bardoxolone and Omaveloxolone, two nuclear factor, erythroid 2 like 2 (NFE2L2) activators as inhibitors of both alpha- and betacoronaviruses. The landscape of coronavirus targeting molecules provides important information for the development of broad-spectrum antivirals reinforcing pandemic preparedness.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.14.452343v1" target="_blank">Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets</a>
</div></li>
<li><strong>Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase</strong> -
<div>
The recent emergence of a novel coronavirus, SARS-CoV-2, has led to the global pandemic of the severe disease COVID-19 in humans. While efforts to quickly identify effective antiviral therapies have focused largely on repurposing existing drugs, the current standard of care, remdesivir, remains the only authorized antiviral intervention of COVID-19 and provides only modest clinical benefits. Here we show that water-soluble derivatives of -tocopherol have potent antiviral activity and synergize with remdesivir as inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). Through an artificial-intelligence-driven in silico screen and in vitro viral inhibition assay, we identified D– tocopherol polyethylene glycol succinate (TPGS) as an effective antiviral against SARS-CoV-2 and {beta}-coronaviruses more broadly that also displays strong synergy with remdesivir. We subsequently determined that TPGS and other water- soluble derivatives of -tocopherol inhibit the transcriptional activity of purified SARS-CoV-2 RdRp and identified affinity binding sites for these compounds within a conserved, hydrophobic interface between SARS-CoV-2 nonstructural protein 7 and nonstructural protein 8 that is functionally implicated in the assembly of the SARS-CoV-2 RdRp. In summary, we conclude that solubilizing modifications to -tocopherol allow it to interact with the SARS-CoV-2 RdRp, making it an effective antiviral molecule alone and even more so in combination with remdesivir. These findings are significant given that many tocopherol derivatives, including TPGS, are considered safe for humans, orally bioavailable, and dramatically enhance the activity of the only approved antiviral for SARS-CoV-2 infection.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.449251v1" target="_blank">Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase</a>
</div></li>
<li><strong>A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates</strong> -
<div>
Vaccines against SARS-CoV-2 have been distributed at massive scale in developed countries, and have been effective at preventing COVID-19. Access to vaccines is limited, however, in low- and middle-income countries (LMICs) due to insufficient supply, high costs, and cold storage requirements. New vaccines that can be produced in existing manufacturing facilities in LMICs, can be manufactured at low cost, and use widely available, proven, safe adjuvants like alum, would improve global immunity against SARS-CoV-2. One such protein subunit vaccine is produced by the Serum Institute of India Pvt. Ltd. and is currently in clinical testing. Two protein components, the SARS-CoV-2 receptor binding domain (RBD) and hepatitis B surface antigen virus-like particles (VLPs), are each produced in yeast, which would enable a low-cost, high-volume manufacturing process. Here, we describe the design and preclinical testing of the RBD-VLP vaccine in cynomolgus macaques. We observed titers of neutralizing antibodies (&gt;104) above the range of protection for other licensed vaccines in non-human primates. Interestingly, addition of a second adjuvant (CpG1018) appeared to improve the cellular response while reducing the humoral response. We challenged animals with SARS-CoV-2, and observed a ~3.4 and ~2.9 log10 reduction in median viral loads in bronchoalveolar lavage and nasal mucosa, respectively, compared to sham controls. These results inform the design and formulation of current clinical COVID-19 vaccine candidates like the one described here, and future designs of RBD-based vaccines against variants of SARS-CoV-2 or other betacoronaviruses.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.452251v1" target="_blank">A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates</a>
</div></li>
<li><strong>Tissue Specific Age Dependence of the Cell Receptors Involved in the SARS-CoV-2 Infection</strong> -
<div>
The coronavirus disease 2019 (COVID-19) pandemic has affected tens of millions of individuals and caused hundreds of thousands of deaths worldwide. Due to its rapid surge, there is a shortage of information on viral behavior and host response after SARS-CoV-2 infection. Here we present a comprehensive, multiscale network analysis of the transcriptional response to the virus. We particularly focus on key-regulators, cell-receptors, and host-processes that are hijacked by the virus for its advantage. ACE2-controlled processes involve a key-regulator CD300e (a TYROBP receptor) and the activation of IL-2 pro-inflammatory cytokine signaling. We further investigate the age-dependency of such receptors and identify the adipose and the brain as potentially contributing tissues for the disease’s severity in old patients. In contrast, several other tissues in the young population are more susceptible to SARS-CoV-2 infection. In summary, this present study provides novel insights into the gene regulatory organization during the SARS-CoV-2 infection and the tissue-specific age dependence of the cell receptors involved in COVID-19.
</div>
<div class="article-link article-html- link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.452256v1" target="_blank">Tissue Specific Age Dependence of the Cell Receptors Involved in the SARS-CoV-2 Infection</a>
</div></li>
<li><strong>Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and related humans in the Netherlands</strong> -
<div>
In the first wave of the COVID-19 pandemic (April 2020), SARS-CoV-2 was detected in farmed minks and genomic sequencing was performed on mink farms and farm personnel. Here, we describe the outbreak and use sequence data with Bayesian phylodynamic methods to explore SARS-CoV-2 transmission in minks and related humans on farms. High number of farm infections (68/126) in minks and farm related personnel (&gt;50% of farms) were detected, with limited spread to the general human population. Three of five initial introductions of SARS-CoV-2 lead to subsequent spread between mink farms until November 2020. The largest cluster acquired a mutation in the receptor binding domain of the Spike protein (position 486), evolved faster and spread more widely and longer. Movement of people and distance between farms were statistically significant predictors of virus dispersal between farms. Our study provides novel insights into SARS-CoV-2 transmission between mink farms and highlights the importance of combing genetic information with epidemiological information at the animal-human interface.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.452160v1" target="_blank">Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and related humans in the Netherlands</a>
</div></li>
<li><strong>hnRNPA1 regulates early translation to replication switch in SARS-CoV-2 life cycle</strong> -
<div>
Our study suggests that methylation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is essential for its optimal replication in the target cells. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1, an RNA- binding protein) was shown to mediate deposition of N6-methyladenosine (m6A) in internal SARS-CoV-2 RNA. The levels of hNRNPA1 expression and extent of methylation varied, depending on the course of SARS-CoV-2 life cycle. The recruitment of eIF4E (translational initiation factor) facilitated viral RNA translation at 1 hour post infection (1 hpi). However, at 2 hpi, methylation of internal SARS-CoV-2 RNA recruited hNRNPA1 which facilitated viral RNA transcription but resulted in translational repression, a phenomenon contributing in understanding the early translation to replication switch in the viral life cycle. Besides, the abrogation of methylation also produced a defective 5’ cap of viral RNA which failed to interact with eIF4E, thereby resulting in a decreased synthesis of viral proteins. To conclude, methylation of the internal and 5’ cap of SARS-CoV-2 RNA was shown to regulate transcription and translation of SARS- CoV-2 in a time dependent manner.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2021.07.13.452288v1" target="_blank">hnRNPA1 regulates early translation to replication switch in SARS-CoV-2 life cycle</a>
</div></li>
<li><strong>STUDY OF BLOOD GROUP ANALYSIS AND ITS CORRELATION WITH LYMPHOPENIA IN COVID 19 INFECTED CASES OUR EXPERIENCE IN TERITARY CARE HOSPITAL.</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
ABSTRACT AIMS AND OBJECTIVES: To study the distribution and frequencies of ABO and Rhesus (Rh) blood groups among confirmed cases of Covid19 infection .We also studied the relation between ABO blood group system and lymphopenia and studied the gender association in COVID19 patients. METHODES A hospital based retrospective study was conducted at Government Medical College Suryapet from1-8-2020 to 30-9-2020. A total of 200 Covid cases were included in the study who came to the hospital with the complaints of Fever, sore throat, body pains, cough, breathlessness, diarrhoea. Patients confirmed Covid infection were tested for blood grouping and RH typing by using forward blood grouping with the help of commercially available standared monoclonal antisera. CBP was processed in sysmax 5 part Haemotology analyzer. Blood group frequency was tested also assed the gender association , covid patients presents with lymphopenia the relation between the ABO blood group and lymphocyte count was determined. RESULTS: Males were more compared to the females .Middle aged group male patients were more commonly involved. Most predominant blood group was group B 79(39.5%), group O 78(39%),group A 37(18.5%), group AB 6(3%),most of them were 190 (95%)Rh positive, only 10 Rh negative (5%).To assess the Lymphopenia in our study we divided the absolute lymphocyte count into 5 groups. Group 1 cases are more 58 (29%), Group 2 91(45.5%), Group 3 30 (15%), Group 4 16(8%), Group 5 5(2.5%). CONCLUSION: Male patients with blood group B were more compared to other blood groups however more number of studies are necessary to confirm these findings in a larger sample and among individuals of different ethnicities. Keywords : ABO , BLOOD GROUPS, Rhesus(Rh) typing.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2021.07.12.21258824v1" target="_blank">STUDY OF BLOOD GROUP ANALYSIS AND ITS CORRELATION WITH LYMPHOPENIA IN COVID 19 INFECTED CASES OUR EXPERIENCE IN TERITARY CARE HOSPITAL.</a>
</div></li>
<li><strong>SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Recent surges in SARS-CoV-2 variants of concern (VOCs) call for the need to evaluate levels of vaccine- and infection- induced SARS-CoV-2 neutralizing antibodies (NAbs). CoronaVac (Sinovac Biotech, Beijing, China) is currently being used for mass vaccination in Thailand as well as other low-income countries. Three VOCs currently circulating within Thailand include the B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) strains. We assessed NAb potency against the prototypic strain containing the original spike sequence (WT) compared to that against the 3 VOCs using sera derived from a cohort of healthcare workers who received a full 2-dose regimen of CoronaVac. Sera from two other cohorts consisting of COVID-19 patients who had been hospitalized in 2020 and 2021 were evaluated for comparison. We found that, despite equally robust production of S1-RBD-binding IgG and 100% seropositivity, sera from both CoronaVac vaccinees and naturally infected individuals had significantly reduced neutralizing capacity against all 3 VOCs compared to WT. Strikingly, NAb titers against Alpha and Beta were comparable, but Delta appears to be significantly more refractory to NAbs in all groups. Our results may help inform on CoronaVac NAb-inducing capacity, which is a proxy for vaccine efficacy, in the context of the WT strain and 3 VOCs. Our results also have critical implications for public health decisionmakers who may need to maintain efficient mitigation strategies amid a potentially high risk for infection with VOCs even in those who have been previously infected.
</p>
</div>
<div class="article-link article-html- link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2021.07.10.21260232v1" target="_blank">SARS- CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients</a>
</div></li>
<li><strong>Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Abstract Background: Coronavirus disease 2019 (COVID-19) is a serious respiratory disease that results from infection with a newly discovered coronavirus (SARS-COV-2). Unfortunately, COVID-19 is not only a short-term infection but that patients (pts) recovering from SARS-CoV2 infection complain of persisting symptoms including: fatigue, diffuse myalgia and weakness, which may lead to chronic fatigue syndrome. There is currently no evidence that nutritional supplements and/or physical exercise can assist in the recovery of pts with chronic fatigue syndrome. 1-Methylnicotinamide (1-MNA) is an endogenic substance that is produced in the liver when nicotinic acid is metabolized. 1-MNA demonstrates anti-inflammatory and anti-thrombotic properties. Therefore, we investigated whether 1-MNA supplements could improve exercise tolerance and decrease fatigue among patients recovering from SARS-CoV-2. Methods: The study population was composed of pts after COVID-19, expressing subjective feelings of limited tolerance to exercise. The selected pts were randomized into two groups: GrM0 without supplementation; GrM1 with 1-MNA supplementation. At the beginning of the study (Phase 0), in both groups, a 6-minute walk test (6MWT) was carried out and fa-tigue assessment with Fatigue Severity Scale (FSS) was performed. After 1 month (Phase 1), a follow up FSS and 6MWT once more were performed in both groups. Results: A significant improvement in the mean distance covered in the 6MWT was noted among the pts in GrM1, compared to those in GrM0. We also noted that in GrM1 the 6MWT distance was significantly higher after 1 month of supplementation with 1-MNA, compared to the beginning of the study (515.18 m in Phase 0 vs 557.8m in Phase 1; p = 0.000034). In GrM1, significantly more pts improved their distance in the 6MWT (23 out of 25 pts, equal to 92%), by a mean of 47 meters, compared to GrM0 (15 of 25 pts, equal to 60%) (p = 0.0061). After one month, significantly more patients in the group without 1-MNA had severe fatigue (FSS ≥ 4) compared to the group with supplementation (GrM1 = 5 pts (20%) vs GrM0 = 14pts (56%); p = 0.008). Conclusions: 1-MNA supplementation significantly improved physical performance in a 6-minute walk test and reduced the percentage of patients with severe fatigue after COVID-19. The comprehensive action of 1-MNA, including anti-inflammatory and anticoagulant effects, as well as activation of the SIRT1 enzyme, may be beneficial for the recovery of patients with persistent symptoms of fatigue and low tolerance to exercise after COVID-19. Keywords: COVID-19, MNA, chronic fatigue syndrome, post-COVID syndrome
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2021.07.14.21259081v1" target="_blank">Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19</a>
</div></li>
<li><strong>Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The adaptive immune system protects against infection via selection of specific antigen receptors on B-cells and T-cells. We studied the prevalent CD8 killer T-cell response mounted against SARS-CoV-2 Spike<sub>269-277</sub> epitope YLQPRTFLL via the most frequent Human Leukocyte Antigen (HLA) class I worldwide, HLA A<em>02. The widespread Spike P272L mutation has arisen in at least 14 different SARS-CoV-2 lineages to date, including in lineages identified as variants of concern. P272L was common in the B.1.177 lineage associated with establishing the second wave in Europe. The large CD8 T-cell response seen across a cohort of HLA A</em>02+ convalescent patients, comprising of over 120 different TCRs, failed to respond to the P272L. Sizable populations (0.01%-0.2%) of total CD8 T-cells from individuals vaccinated against SARS-CoV-2 stained with HLA A*02-YLQPRTFLL multimers but failed to bind to the P272L reagent. Viral escape at prevalent T-cell epitopes restricted by high frequency HLA may be particularly problematic when vaccine immunity is focussed on a single protein such as SARS-CoV-2 Spike and provides a strong argument for inclusion of multiple viral proteins in next generation vaccines and highlights the urgent need for monitoring T-cell escape in new SARS-CoV-2 variants.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2021.06.21.21259010v2" target="_blank">Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope</a>
</div></li>
</ul>
<h1 data-aos="fade-right" id="from-clinical-trials">From Clinical Trials</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>COVID-19 Vaccinations With a Sweepstakes</strong> - <b>Condition</b>:   Covid19<br/><b>Intervention</b>:   Behavioral: Philly Vax Sweepstakes<br/><b>Sponsors</b>:  <br/>
University of Pennsylvania;   Philadelphia Department of Public Health<br/><b>Active, not recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A Study of PF-07321332/Ritonavir in Nonhospitalized High Risk Adult Participants With COVID-19</strong> - <b>Condition</b>:   COVID-19<br/><b>Interventions</b>:   Drug: PF-07321332;   Drug: Ritonavir;   Drug: Placebo<br/><b>Sponsor</b>:   Pfizer<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans’ Perceptions/Beliefs About COVID-19 Testing and Vaccination Study</strong> - <b>Condition</b>:   Covid19 Virus Infection<br/><b>Intervention</b>:   Behavioral: Protect Your Elders Campaign<br/><b>Sponsors</b>:   North Carolina Central University;   Lumbee Tribe of North Carolina;   University of North Carolina at Pembroke<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents</strong> - <b>Condition</b>:   Covid19 Vaccine<br/><b>Interventions</b>:   Biological: MVC-COV1901(S protein with adjuvant);   Biological: MVC-COV1901(Saline)<br/><b>Sponsor</b>:   Medigen Vaccine Biologics Corp.<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector)</strong> - <b>Condition</b>:   COVID-19<br/><b>Interventions</b>:   Biological: Recombinant SARS-CoV-2 Ad5 vectored vaccine;   Biological: Inactive SARS-CoV-2 vaccine (Vero cell)<br/><b>Sponsors</b>:   Jiangsu Province Centers for Disease Control and Prevention;   CanSino Biologics Inc.<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Covid-19 Virtual Recovery Study</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Behavioral: Strength RMT;   Behavioral: Strength RMT and nasal breathing;   Behavioral: Endurance RMT;   Behavioral: Endurance RMT and nasal breathing;   Behavioral: Low dose RMT<br/><b>Sponsor</b>:   Mayo Clinic<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Efficacy of Amantadine Treatment in COVID-19 Patients</strong> - <b>Condition</b>:   Patients With Moderate or Severe COVID-19<br/><b>Intervention</b>:   Drug: Amantadine<br/><b>Sponsors</b>:   Noblewell;   Medical Research Agency (ABM);   Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University in Katowice<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Internet-based Multidisciplinary Rehabilitation for Longterm COVID-19 Syndrome</strong> - <b>Condition</b>:   Long COVID-19<br/><b>Intervention</b>:   Behavioral: Multidisciplinary Rehabilitation<br/><b>Sponsors</b>:   Danderyd Hospital;   St Göran Hospital, Stockholm<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A Different Use of The Aerosol Box in COVID-19 Patients; Internal Jugular Vein Cannulation</strong> - <b>Condition</b>:   COVID-19 Pneumonia<br/><b>Intervention</b>:   Procedure: Internal jugular vein cannulation<br/><b>Sponsor</b>:   Bakirkoy Dr. Sadi Konuk Research and Training Hospital<br/><b>Completed</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Reconditioning Exercise for COVID-19 Patients Experiencing Residual sYmptoms</strong> - <b>Condition</b>:   Covid19<br/><b>Intervention</b>:   Other: Exercise Therapy<br/><b>Sponsor</b>:  <br/>
Wake Forest University Health Sciences<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Lipid Emulsion Infusion and COVID-19 Patients</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Drug: SMOFlipid;   Other: 0.9% saline<br/><b>Sponsor</b>:   Assiut University<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease</strong> - <b>Condition</b>:   Covid19<br/><b>Intervention</b>:   Drug: cholecalciferol 6 lakh IU<br/><b>Sponsor</b>:  <br/>
Postgraduate Institute of Medical Education and Research<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Immunogenicity and Safety of an Inactivated COVID-19 Vaccine</strong> - <b>Condition</b>:   COVID-19<br/><b>Interventions</b>:   Biological: Inactivated COVID-19 Vaccine;   Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: Inactivated Hepatitis A Vaccine<br/><b>Sponsor</b>:  <br/>
Sinovac Research and Development Co., Ltd.<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Coenzyme Q10 as Treatment for Long Term COVID-19</strong> - <b>Conditions</b>:   Covid19;   Long Term Covid19<br/><b>Interventions</b>:   Drug: Coenzyme Q10;   Drug: Placebo<br/><b>Sponsors</b>:   Aarhus University Hospital;   University of Aarhus;   Pharma Nord<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge</strong> - <b>Condition</b>:   COVID-19<br/><b>Intervention</b>:   Device: NovoTTF-100L<br/><b>Sponsor</b>:   NovoCure GmbH<br/><b>Completed</b></p></li>
</ul>
<h1 data-aos="fade-right" id="from-pubmed">From PubMed</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway</strong> - SARS-CoV-2 can infect multiple organs, including lung, intestine, kidney, heart, liver, and brain. The molecular details of how the virus navigates through diverse cellular environments and establishes replication are poorly defined. Here, we generated a panel of phenotypically diverse, SARS-CoV-2-infectable human cell lines representing different body organs and performed longitudinal survey of cellular proteins and pathways broadly affected by the virus. This revealed universal inhibition of…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples</strong> - The aim of this study was to identify and validate a sensitive, high-throughput, and cost-effective SARS-CoV-2 real-time RT-PCR assay to be used as a surveillance and diagnostic tool for SARS-CoV-2 in a university surveillance program. We conducted a side-by-side clinical evaluation of a newly developed SARS-CoV-2 multiplex assay (EZ-SARS-CoV-2 Real-Time RT-PCR) with the commercial TaqPath COVID-19 Combo Kit, which has an Emergency Use Authorization from the FDA. The EZ- SARS-CoV-2 RT-PCR…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Chemical design principles of next-generation antiviral surface coatings</strong> - The ongoing coronavirus disease 2019 (COVID-19) pandemic has accelerated efforts to develop high-performance antiviral surface coatings while highlighting the need to build a strong mechanistic understanding of the chemical design principles that underpin antiviral surface coatings. Herein, we critically summarize the latest efforts to develop antiviral surface coatings that exhibit virus-inactivating functions through disrupting lipid envelopes or protein capsids. Particular attention is…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Covalent Antiviral Agents</strong> - Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance. Covalent inhibitors have the potential to achieve both goals owing to their biochemical efficiency, prolonged duration of action, and the capability to inhibit shallow,…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate</strong> - Viral mRNA cap methyltransferases (MTases) are emerging targets for the development of broad-spectrum antiviral agents. In this work, we designed potential SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitors by using bioisosteric substitution of the sulfonium and amino acid substructures of the cosubstrate S-adenosylmethionine (SAM), which serves as the methyl donor in the enzymatic reaction. The synthetically accessible target structures were prioritized using molecular docking. Testing of the…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma</strong> - The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies in the serum of an individual indicates prior infection or vaccination. However, it provides limited insight into the protective nature of this immune response. Neutralizing antibodies recognizing the viral spike protein are more revealing, yet their measurement traditionally requires virus- and cell-based systems that are costly, time-consuming, inflexible, and potentially biohazardous. Here, we…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations</strong> - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused worldwide pandemic and is responsible for millions of worldwide deaths due to -a respiratory disease known as COVID-19. In the search for a cure of COVID-19, drug repurposing is a fast and cost-effective approach to identify anti-COVID-19 drugs from existing drugs. The receptor binding domain (RBD) of the SARS-CoV-2 spike protein has been a main target for drug designs to block spike protein binding to ACE2 proteins. In this…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Reconfiguration and dedifferentiation of functional networks during cognitive control across the adult lifespan</strong> - Healthy aging is accompanied by reduced cognitive control and widespread alterations in the underlying brain networks; but the extent to which large-scale functional networks in older age show reduced specificity across different domains of cognitive control is unclear. Here we use cov-STATIS (a multi-table multivariate technique) to examine similarity of functional connectivity during different domains of cognitive control-inhibition, initiation, shifting, and working memory-across the adult…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma</strong> - INTRODUCTION: Favipiravir is an antiviral agent that is recently used for SARS-CoV2 infection. The drug-drug interactions of favipiravir especially with chemotherapeutic agents in a patient with malignancy are not well known.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination</strong> - A variety of autoimmune disorders have been reported after viral illnesses and specific vaccinations. Cases of de novo immune thrombocytopenia (ITP) have been reported after SARS-CoV-2 vaccination, although its effect on preexisting ITP has not been well characterized. In addition, although COVID-19 has been associated with complement dysregulation, the effect of SARS-CoV-2 vaccination on preexisting complementopathies is poorly understood. We sought to better understand SARS-CoV-2…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>SSRIs: Applications in inflammatory lung disease and implications for COVID-19</strong> - Selective serotonin reuptake inhibitors (SSRIs) have anti-inflammatory properties that may have clinical utility in treating severe pulmonary manifestations of COVID-19. SSRIs exert anti-inflammatory effects at three mechanistic levels:</li>
</ul>
<ol type="a">
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">inhibition of proinflammatory transcription factor activity, including NF-κB and STAT3; (b) downregulation of lung tissue damage and proinflammatory cell recruitment via inhibition of cytokines, including IL-6, IL-8, TNF-α, and IL-1β; and (c) direct…</li>
</ol>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Cationic Compounds with SARS-CoV-2 Antiviral Activity and their Interaction with OCT/MATE Secretory Transporters</strong> - In the wake of the COVID-19 pandemic, drug repurposing has been highlighted for rapid introduction of therapeutics. Proposed drugs with activity against SARS-CoV-2 include compounds with positive charges at physiological pH, making them potential targets for the organic cation (OC) secretory transporters of kidney and liver, i.e., the basolateral Organic Cation Transporters, OCT1 and OCT2; and the apical Multidrug And Toxin Extruders, MATE1 and MATE2-K. We selected several compounds proposed to…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>COVID-19 diagnosis and testing in pediatric heart transplant recipients</strong> - Pediatric heart transplant recipients have been expected to be at higher risk of adverse events from developing COVID-19 infection. COVID-19 RNA PCR and antibody testing has been performed in our cohort of patients since March 15, 2020 and outcomes were reviewed. COVID-19 infection in our population of pediatric heart transplant recipients is common (21%), despite recommendations to avoid contact with others. Asymptomatic COVID-19 infection is common as well (55%). Despite the frequency of…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Determination of camostat and its metabolites in human plasma - preservation of samples and quantification by a validated UHPLC-MS/MS method</strong> - CONCLUSIONS: A methodology was developed that preserves camostat and GBPA in plasma samples and provides accurate and sensitive quantification of camostat, GBPA and GBA by UHPLC-MS/MS.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Accurate Bulk Quantitation of Droplet Digital Polymerase Chain Reaction</strong> - Droplet digital PCR provides superior accuracy for nucleic acid quantitation. The requirement of microfluidics to generate and analyze the emulsions, however, is a barrier to its adoption, particularly in low resource settings or clinical laboratories. Here, we report a novel method to prepare ddPCR droplets by vortexing and readout of the results by bulk analysis of recovered amplicons. We demonstrate the approach by accurately quantitating SARS-CoV-2 sequences using entirely bulk processing…</p></li>
</ul>
<h1 data-aos="fade-right" id="from-patent-search">From Patent Search</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Advanced Machine Learning System combating COVID-19 virus Detection, Spread, Prevention and Medical Assistance.</strong> - - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=AU329799475">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Differential detection kit for common SARS-CoV-2 variants in COVID-19 patients</strong> - - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=AU328840861">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>SARS-CoV-2 anti-viral therapeutic</strong> - - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=AU327160071">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>一种基于联邦学习的多用户协同训练人流统计方法及系统</strong> - 本发明提供一种基于联邦学习的多用户协同训练人流统计方法，旨在利用联邦学习框架搭建一个新颖的人群计数模型，达到让多用户多设备同时训练的目的。各个客户端利用图像数据集对图像分类网络进行本地训练以获取本地模型；在各经过至少一次本地训练后，中心服务器从客户端获取本地模型的权值及附加层参数并进行聚合处理；中心服务器利用聚合处理后的权值及附加层参数更新全局模型，并将聚合处理后的权值参数及附加层参数返回给各个客户端；各个客户端利用中心服务器返回的权值以及ground truth值进行贝叶斯估计，计算loss值，并利用返回的权值参数及附加层参数更新本地模型；重复执行直至所有客户端的loss值均收敛，则完成人流统计全局模型和本地模型的训练。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN329978461">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A POLYHERBAL ALCOHOL FREE FORMULATION FOR ORAL CAVITY</strong> - The present invention generally relates to a herbal composition. Specifically, the present invention relates to a polyherbal alcohol free composition comprising of Glycyrrhiza glabra root extract, Ocimum sanctum leaf extract, Elettaria cardamomum fruit extract, Mentha spicata (Spearmint) oil and Tween 80 and method of preparation thereof. The polyherbal alcohol free composition of the present invention possesses excellent antimicrobial properties and useful for oral cavity. - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=IN325690740">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>新型冠状病毒B.1.351南非突变株RBD的基因及其应用</strong> - 本发明属于生物技术领域，具体涉及新型冠状病毒B.1.351南非突变株RBD的基因及其应用。本发明的新型冠状病毒B.1.351南非突变株RBD的基因，其核苷酸序列如SEQIDNO.1或SEQIDNO.6所示。本发明通过优化野生型新型冠状病毒南非B.1.351南非突变株RBD的基因序列，并结合筛选确定了相对最佳序列，优化后序列产生的克隆表达效率比野生型新型冠状病毒B.1.351南非突变株RBD序列表达效率大幅提高，从而，本发明的新型冠状病毒B.1.351南非突变株RBD的基因可以用于制备新型冠状病毒疫苗。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN328990628">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>检测新型冠状病毒中和抗体的试剂盒及其应用</strong> - 本发明涉及生物技术领域，具体而言，提供了一种检测新型冠状病毒中和抗体的试剂盒及其应用。本发明提供的检测新型冠状病毒中和抗体试剂盒，具体包括（a）或（b）两种方案：（a）示踪物标记的RBD三聚体抗原，包被在固体支持物上的ACE2，以及，含有0.2‑10mg/mL十二烷基二甲基甜菜碱的工作液；（b）示踪物标记的ACE2，包被在固体支持物上的RBD三聚体抗原，以及，含有0.2‑10mg/mL十二烷基二甲基甜菜碱的工作液；其中，RBD三聚体抗原利用二硫键将刺突蛋白的RBD与S2亚基完全交联得到。十二烷基二甲基甜菜碱会显著提高RBD三聚体抗原与新冠中和性抗体结合速度，提升阳性样本平均发光强度，缩短检测时间。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN328990376">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>一种检测SARS-CoV-2的引物组合物及其应用</strong> - 本发明涉及一种检测SARS‑CoV‑2的引物组合物及其应用。所述引物组合物包括SEQ ID NO:1~SEQ ID NO:12所示的核酸序列。本发明利用所述引物组合物进行逆转录巢式PCR，并结合Sanger测序，能够快速、准确地获取SARS‑CoV‑2基因信息，从而能够实现快速检测SARS‑CoV‑2以及判断SARS‑CoV‑2突变株，且具备良好的准确性、灵敏度、特异性以及重复性。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN328990422">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>基于多重荧光定量PCR技术的新冠病毒突变序列检测技术及其应用</strong> - 本发明提供一种基于多重荧光定量PCR技术的新冠病毒突变类型检测技术及其应用。本发明主要基于荧光定量PCR技术针对目前S基因重要突变类型，如序列位置23403，序列变化A&gt;G、序列位置23063，序列变化A&gt;T、序列位置22812‑22813，序列变化AG&gt;GA、序列位置23012，序列变化G&gt;A进行单管或多管多重检测。其试剂盒可以很好的鉴别目前流行的D614G、N501Y、K417N、E484K重要突变株且特异性好，对新冠病毒的突变监测具有十分积极的意义。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN329978220">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>基于荧光定量PCR技术的新冠病毒新型核酸突变检测技术及其应用</strong> - 本发明提供一种基于荧光定量PCR技术的新冠病毒新型核酸突变检测技术及其应用。本发明主要基于荧光定量PCR技术针对目前S基因新突变‑双重变异（E484Q和L452R突变）进行检测。本发明提供的试剂盒可以很好的鉴别E484Q和L452R突变，对新冠病毒的新突变快速监测具有十分积极的意义。 - <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=CN329978219">link</a></p></li>
</ul>
<script>AOS.init();</script></body></html>

472
archive-daily-dose/15 July, 2021.html Normal file
View File

@ -0,0 +1,472 @@
<!DOCTYPE html>
<html lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml"><head>
<meta charset="utf-8"/>
<meta content="pandoc" name="generator"/>
<meta content="width=device-width, initial-scale=1.0, user-scalable=yes" name="viewport"/>
<title>15 July, 2021</title>
<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
</style>
<title>Daily-Dose</title><meta content="width=device-width, initial-scale=1.0" name="viewport"/><link href="styles/simple.css" rel="stylesheet"/><link href="../styles/simple.css" rel="stylesheet"/><style>*{overflow-x:hidden;}</style><link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet"/><script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script></head>
<body>
<h1 data-aos="fade-down" id="daily-dose">Daily-Dose</h1>
<h1 data-aos="fade-right" data-aos-anchor-placement="top-bottom" id="contents">Contents</h1>
<ul>
<li><a href="#from-new-yorker">From New Yorker</a></li>
<li><a href="#from-vox">From Vox</a></li>
<li><a href="#from-the-hindu-sports">From The Hindu: Sports</a></li>
<li><a href="#from-the-hindu-national-news">From The Hindu: National News</a></li>
<li><a href="#from-bbc-europe">From BBC: Europe</a></li>
<li><a href="#from-ars-technica">From Ars Technica</a></li>
<li><a href="#from-jokes-subreddit">From Jokes Subreddit</a></li>
</ul>
<h1 data-aos="fade-right" id="from-new-yorker">From New Yorker</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>The Biden Antitrust Revolution</strong> - A new executive order calls for the federal government to work proactively to end monopolies that undermine economic fairness and American democracy. - <a href="https://www.newyorker.com/news/our-columnists/the-biden-antitrust-revolution">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Britney Spears’s Conservatorship Nightmare</strong> - How the pop star’s father and a team of lawyers seized control of her life—and have held on to it for thirteen years. - <a href="https://www.newyorker.com/news/american-chronicles/britney-spears-conservatorship-nightmare">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Who Owns Mike Disfarmer’s Photographs?</strong> - Strangers made his small-town portraits famous in the art world. Decades later, his heirs want control of the estate. - <a href="https://www.newyorker.com/news/us-journal/who-owns-mike-disfarmers-photographs">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>The Assassination of Haiti’s President</strong> - Jovenel Moïse’s family deserves justice for his horrific killing. So do all of the Haitian families who suffered during his rule. - <a href="https://www.newyorker.com/news/news-desk/the-assassination-of-haitis-president">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>We Need the “Whole-of-Government” Climate Fight That Biden Promised</strong> - Some agencies are shirking—even as the heat keeps dialling up. - <a href="https://www.newyorker.com/news/annals-of-a-warming-planet/we-need-the-whole-of-government-climate-fight-that-%20biden-promised">link</a></p></li>
</ul>
<h1 data-aos="fade-right" id="from-vox">From Vox</h1>
<ul>
<li><strong>Making sense of the recent Covid-19 spike</strong> -
<figure>
<img alt="" src="https://cdn.vox-
cdn.com/thumbor/wPJzQBYal76XuKEDoyD7fT20Qfs=/0x0:5547x4160/1310x983/cdn.vox-
cdn.com/uploads/chorus_image/image/69584996/GettyImages_1328577491t.0.jpg"/>
<figcaption>
Commuters wearing protective face masks ride a bus in Brooklyn, New York on July 13, 2021. | NEW YORK, NEW YORK - JULY 13: People ride a bus in a Brooklyn neighborhood which is witnessing a rise in COVID-19 cases on July 13, 2021 in New York City. Across the city some neighborhoods are witnessing a rise in cases in what health officials blame on low vaccination rates and more transmissible variants like delta. According to data from Johns Hopkins University, 45 states have rates of new cases this past week are at least 10% higher than the rates of new cases the previous week. (Photo by Spencer Platt/Getty Images)
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The pandemic isn’t over in the US — but it is changing.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="634wAf">
<a href="https://www.vox.com/coronavirus-covid19">Covid-19 cases</a> are on the rise in the United States again. But this time, the story is more complicated than it was in previous waves.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ysqiQW">
Since early January, when the United States hit a peak of 260,000 new cases every day on average, case numbers have been in more or less constant decline. Tens of millions of people were <a href="https://www.vox.com/covid-19-coronavirus-treatment-
prevention-cure-vaccines">inoculated against Covid-19</a> in the following months. By late June, the country was averaging just 11,000 new cases per day, according to <a href="https://www.nytimes.com/interactive/2021/us/covid-
cases.html">the New York Times tracker</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="y0aYgG">
But as of July 13, the US is seeing about 25,000 new cases daily on average, double the case levels of just a few weeks ago.
</p>
<figure class="e-image">
<img alt=" " src="https://cdn.vox-cdn.com/thumbor/53ufcD7Hq2QKSVQpjGvsW_1iOD0=/800x0/filters:no_upscale()/cdn.vox-
cdn.com/uploads/chorus_asset/file/22716886/coronavirus_data_explorer__6_.png"/> <cite>Our World In Data</cite></figure></li>
</ul>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="mwxBzV">
So far, hospitalizations have not increased as much: They’re up only slightly, from a seven-day average of 16,500 two weeks ago to about 19,500. Deaths, likewise, are still quite low: a daily average of 330 per day, compared to January when the US was losing more than 3,000 people per day. Both measures are still growing, if not yet as rapidly as cases.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="c4KAFB">
<a href="https://www.vox.com/2020/7/6/21314472/covid-19-coronavirus-us-cases-
deaths-trends-wtf">Confirmed cases are a leading indicator</a>. Somebody tests positive for the disease, but it may take two weeks for them to become sick enough to go to the hospital and even longer for them to die if they do not recover. (One caveat: Testing rates have <a href="https://coronavirus.jhu.edu/testing/individual-states">dropped significantly</a> in the past few months, so we may not be detecting every new case. But that only makes the rise in confirmed cases more concerning.)
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="S48SLJ">
This is still true — when cases accelerate, so do deaths, eventually — and the current trends reflect that basic reality.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="wjAKpR">
But this time, about half of the country is now fully vaccinated against Covid-19. Some of those people could still contract the virus, but their illness is much more likely to be mild if they have received the vaccine. The Biden administration <a href="https://www.cnbc.com/2021/07/08/covid-vaccines-nearly-all-deaths-hospitalizations-among-
unvaccinated.htmlt">announced</a> last week that nearly all the Covid-19 hospitalizations and deaths being reported now are of unvaccinated people.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="WCFotR">
“The decoupling between cases and deaths has really occurred,” Andrew Pavia, who specializes in infectious diseases at the University of Utah, told reporters at an Infectious Diseases Society of America briefing this week. “We’re seeing an increase in deaths but not nearly to the degree previously.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="xl8PSA">
Still, so long as the virus is circulating, there are risks, especially to the half of the population who haven’t been vaccinated. The delta variant appears more transmissible and virulent than those that came before it, and, while the vaccines seem to be holding up well against it, it is still accounting for a bigger and bigger share of cases in the US.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="7uanwb">
Hospitalizations and deaths are also becoming more prevalent among younger people, another distinction from prior surges.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="OHVTBR">
All in all, the situation is much messier than it was last year, when hospitalizations and deaths would grow like clockwork following a rise in cases. Here are three factors to keep in mind going forward.
</p>
<h3 id="gvQV5O">
<ol type="1">
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">Unvaccinated people are still very vulnerable to Covid-19
</li></ol></h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="nunc89">
If you have not been vaccinated, you do not have protection against the coronavirus — and the increasingly prevalent delta variant appears more dangerous than previous iterations of the virus. Right now, it accounts for nearly half of new cases in the US, and it is expected to become the dominant strain.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="RGCqZJ">
As <a href="https://www.vox.com/22547537/delta-coronavirus-variant-covid-19-vaccines-masks-lockdown">Vox’s Umair Irfan explained</a>, the delta variant appears to be 60 percent more transmissible than the alpha variant first identified in the United Kingdom — which was likely already 60 percent more transmissible than the version of the virus first identified in humans.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FlxVPi">
Early evidence would suggest the delta variant is also more virulent: A study conducted in Scotland found that people who had contracted the delta variant were twice as likely to end up in the hospital, though the death rate did not appear to be significantly worse.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="QdX0fH">
“As greater numbers of non- vaccinated persons acquire the delta variant, hospitalizations may indeed rise,” David Celentano, an epidemiologist at the John Hopkins School of Public Health, told me.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="PWVEXW">
Different states also have different degrees of vulnerability, with vaccination rates by state ranging from 78 percent of Vermonters being fully vaccinated to just 42 percent of Alabamians. That has translated to the growth in cases: The states seeing the most new cases (including parts of the South, Midwest, and the West) <a href="https://www.nytimes.com/interactive/2021/us/covid-cases.html">per capita</a> all rank in <a href="https://www.nytimes.com/interactive/2020/us/covid-19-vaccine-doses.html">the bottom half of states</a> in vaccination rates.
</p>
<figure class="e-image">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><img alt=" " src="https://cdn.vox-
cdn.com/thumbor/s2dvg5Ytu6k4MH93gGhK1HGOAFA=/800x0/filters:no_upscale()/cdn.vox-
cdn.com/uploads/chorus_asset/file/22718852/GettyImages_1310033214t.jpg"/> <cite>Mario Tama/Getty Images</cite></p>
<figcaption>
A healthcare worker passes out water to people waiting in the observation area after receiving a dose of a COVID-19 vaccine on March 30, 2021, in Apple Valley, California.
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="XyzANV">
Then there is the changing nature of which age groups are being affected by Covid-19: According to <a href="https://www.kff.org/coronavirus-covid-19/dashboard/kff-covid-19-vaccine-monitor-dashboard/">the Kaiser Family Foundation’s polling</a>, 85 percent of all people 65 and over say they have been vaccinated. But that percentage drops among younger cohorts, to 66 percent of people 50 to 64, 59 percent of people 30 to 49, and 55 percent of people 18 to 29.
</p>
<h3 id="O1OfeE">
<ol start="2" type="1">
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">Vaccines are protecting the people most vulnerable to Covid-19
</li></ol></h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="suo0WX">
These trends contain both good and bad news. The bad news is self-evident: Because younger people and people in certain states are less likely to have been vaccinated against Covid-19, they remain more likely to contract the disease. Especially as the delta variant becomes more dominant, a higher share of them will end up in the hospital. Some will die.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="WBTAqD">
According to <a href="https://gis.cdc.gov/grasp/covidnet/COVID19_5.html">CDC data</a>, the share of people hospitalized with Covid-19 who are ages 18 to 49 has grown from 20 percent of the total in January to more than 40 percent now. Americans 65 and over made up more than half of Covid-19 hospitalizations in January; they now account for less than 30 percent.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="WCfDm0">
To be clear: Overall hospitalizations are still way down from their peak, so the raw number of young people getting seriously ill is not as large as the number of hospitalizations among older people during the worst of the winter surge. But, relatively speaking, younger people are now making up a bigger share of hospitalizations.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="7Pj1LF">
The good news is the other side of this trend: The people who are the most vulnerable to dying of Covid-19 have much more robust protection than they did last year. We have known <a href="https://www.vox.com/2020/3/23/21190033/coronavirus-covid-19-deaths-by-age">from the start of the pandemic</a> that age, as much as anything, is the best proxy for a person’s risk of succumbing to Covid-19.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="2bHyJr">
That’s why nursing home residents and workers were prioritized when mass vaccinations began in early 2021. According to <a href="https://www.aarp.org/caregiving/health/info-2021/nursing-home-staff-still-unvaccinated-for-covid.html">an AARP analysis of federal data</a>, nearly 80 percent of people residing in nursing homes were fully vaccinated against Covid-19 as of late June.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ezYmVs">
Over the course of the pandemic, they have accounted for a disproportionate share of Covid-19 deaths — <a href="https://data.cms.gov/stories/s/COVID-19-Nursing-Home-Data/bkwz-
xpvg/">133,482</a> out of <a href="https://coronavirus.jhu.edu/map.html">608,000</a> total US deaths. But death rates among that population slowed significantly once vaccinations took off. In early January, US nursing homes reported more than 5,000 resident deaths every week, according to <a href="https://data.cms.gov/stories/s/COVID-19-Nursing-Home-
Data/bkwz-xpvg/">federal data</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="hTrbFR">
In the last week of June, nursing homes reported just 147 resident deaths. That represents remarkable progress in protecting the most vulnerable.
</p>
<h3 id="7vviUs">
<ol start="3" type="1">
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">Vaccinated people can contract Covid-19, but cases are almost always mild
</li></ol></h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ArWNch">
The Covid-19 vaccines are very good, but they aren’t perfect. Some number of people who have been fully vaccinated will contract the coronavirus, and they may also account for some of the rising case numbers.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="tZhHXU">
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="j6myyk">
When the <a href="https://www.vox.com/22167841/fda-vaccine-approval-pfizer-biontech-covid-19-eua-coronavirus">Pfizer/BioNTech</a> and <a href="https://www.vox.com/2020/12/17/22180356/moderna-covid-19-vaccine-approved-fda-emergency-use-
pfizer">Moderna</a> vaccines were first approved, it was the astounding efficacy rates that got all the attention, preventing any kind of illness in 95 percent of people during the clinical trials. But even then, that meant 5 percent of vaccinated people did get sick.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FpvTvx">
That share will grow as the delta variant becomes more dominant; as Irfan <a href="https://www.vox.com/22547537/delta-coronavirus-variant-covid-19-vaccines-masks-lockdown">reported</a>, the initial evidence suggests the Pfizer/BioNTech vaccine is still 80 percent effective in preventing illness. But that means a larger number of vaccinated people may contract the virus and feel symptoms as the variant continues to spread.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="YcwyH5">
That is still a high success rate. The World Health Organization <a href="https://www.cnbc.com/2021/07/12/most-fully-vaccinated-people-who-get-covid-delta-infections-are-asymptomatic-who-
says-.html">said</a> this week that most vaccinated people who do contract the delta variant experience no symptoms. They may also be less likely to spread the virus, as they appear to shed less of it, CDC Deputy Director Jay Butler told reporters at the Infectious Diseases Society of America briefing.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Sv0CAv">
And the vaccines are still providing impressive protection against severe illness, which is reflected in the minuscule number of vaccinated people being hospitalized or dying of Covid-19.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="lLcM0m">
“Breakthrough infections tend to be milder,” Butler said. “Even if infection occurs, [vaccination] decreases the risk of hospitalizations and death.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="wQYEdW">
Rising cases are not ideal. Millions of Americans are still vulnerable to Covid-19, and a more dangerous variant of the virus is taking hold. The number of deaths occurring each day is still the equivalent of a jetliner crashing every 24 hours.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="e3pbEo">
But this is a different kind of wave than the ones that preceded it, with nearly 160 million Americans and counting now fully vaccinated. The solution is the same as it’s been for the past six months, as Celentano told me over email: “The best way to avoid the acquisition of SARS-CoV-2 is to get vaccinated now!”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="GNfzYA">
Otherwise, as long as the virus is circulating, there are risks.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="XhzCsE">
“The more virus that circulates, the more mutations that occur, and greater chance of the emergence of yet another new variant,” Jen Kates, director of global health at the Kaiser Family Foundation, told me.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="IjUQjt">
A new variant that is more deadly, more transmissible, or more resistant to vaccines “would of course have more severe public health implications.”
</p>
<ul>
<li><strong>Facebook wants creators, but YouTube is paying creators much, much more</strong> -
<figure>
<img alt="" src="https://cdn.vox-
cdn.com/thumbor/orJ17hDrnoamAgZhWTUFJhrkOpo=/546x0:7101x4916/1310x983/cdn.vox-
cdn.com/uploads/chorus_image/image/69584909/1327685551.0.jpg"/>
<figcaption>
Mark Zuckerberg at the Sun Valley media and tech conference, July 2021. | Kevin Dietsch/Getty Images
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
YouTube gives half its revenue to the people who make its videos. Facebook — despite a $1 billion pledge — doesn’t want to do that.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="KD7ZPF">
Facebook has nearly 2.9 billion users, so lots of people use Facebook to reach that giant audience. But Facebook wants even more people posting more stuff on its platforms, so it’s <a href="https://www.facebook.com/zuck/posts/10113607549897721">going to pay out $1 billion by the end of 2022</a> to encourage creators — people who make internet content for fun and profit but generally aren’t running full-fledged media companies — to make stuff for Facebook and Instagram. The impetus here is clear: Facebook wants more engaging stuff on its apps, and it’s also trying to compete with the likes of TikTok, Snapchat, and YouTube.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="0ZNiXp">
Rewarding people who make stuff for you by paying them is a well-worn playbook for the big internet platforms. Yes, they would really rather have you give them your stuff for free — and you are very much welcome to continue giving Mark Zuckerberg pictures of your dogs and kids. Still, Facebook and its competitors have come to realize that people who are really good at making things often want to get paid for those things. So, fine.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="DvDwFB">
But it’s worth noting that there’s a meaningful difference between Facebook’s newest gambit and the one that Google’s YouTube has been using to great success: Facebook, for now, is giving creators a lot less money.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="f6bOyn">
When you make stuff for YouTube, you get a chance to make money the same way YouTube makes money — from ads that run next to the videos you upload to YouTube. At Facebook, though, there are two different pools of money: One is generated by ads connected to the videos and photos you post on Facebook, and the other is generated by ads everywhere else on Facebook. The first pool is the one that Facebook’s creators can access. The other one is really, really, big. And that’s the one Facebook is keeping all for itself.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="upqd70">
This is one of those that’s a little easier to understand with visual aids. So: Here’s a YouTube video by Mr. Beast, the site’s most popular creator. YouTube gets paid for the ads that run before and during the clip, and Jimmy Donaldson, the 23-year-old behind Mr. Beast, gets 55 percent of the revenue those ads generate.
</p>
<div id="5xWBxe">
<div style="width: 100%; height: 0; padding-bottom: 56.25%;">
</div>
</div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="fiwp5r">
YouTube can also make money other ways, like selling banner ads on its homepage. But the vast majority of its money comes from ads attached directly to the videos it shows to more than 2 billion people every month. So YouTube is directly aligned with the people who generate the stuff that powers YouTube.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="OxENnl">
At Facebook, though, that connection is much weaker. In theory, Facebook can run ads on videos on things like IG TV, its attempt to create a sorta-YouTube. But most of the money that Facebook makes from ads — and Facebook makes nearly all of its money from ads — isn’t<em> </em>tied directly to content users post there. If you flip through Instagram and see a Nike ad, that ad floats on its own. It’s not tethered to a post from The Rock or Kylie Jenner. The same goes for your Facebook News Feed.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="O7Hgfp">
So though Facebook has some ways to share revenue directly with creators, it usually doesn’t give them a cut of money associated with their content. And it’s why lots of the new programs Zuckerberg laid out today are generally connected to frequency or performance — Facebook is fuzzy about what exactly performance means, though — as opposed to the revenue the content generates.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ydZtsV">
Which means there’s a real money gap for creators who thrive on Facebook versus those on YouTube; it’s why top YouTube creators like Donaldson stick with YouTube instead of trying to branch out onto other platforms. And it’s why <a href="https://blog.youtube/inside-youtube/letter-from-
susan-our-2021-priorities/">YouTube says it paid out $30 billion to its content partners over the last three years</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="xiwIv7">
So if Facebook really wants people to put engaging stuff on Facebook so it can compete with YouTube and TikTok and Twitter and Snapchat, why not give them a chance to make more money?
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="2dgbxc">
People familiar with the company tell me there are two reasons. The first is practical: On YouTube, it’s easy to understand that someone who watched a Mr. Beast video watched the ad that ran before it. On Facebook or Instagram, though, it would be difficult to attribute the connection between the Airbnb ad you scrolled past and the Ariana Grande post you eventually landed on.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ueWnB7">
The second reason is philosophical, and perhaps more important: I’m told that Mark Zuckerberg doesn’t think Facebook content-makers should get a cut of all of Facebook’s revenue. And that while he’s happy Facebook content-makers are giving him content, he thinks he can replace them with others if they don’t like the terms.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ge8FfT">
That philosophy runs a bit contrary to the fact that Facebook has just said it’s going to spend $1 billion to prompt people to give it content — Facebook clearly feels that it has to compete for creators’ time and energy. On the other hand, $1 billion over a year is much less than $30 billion over three years.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="PknWBF">
And, to put a fine point on it, the “our content makes Facebook more valuable so Facebook should pay us for it” argument is the one that lawmakers in Australia and an increasing number of European countries are making to justify <a href="https://www.bbc.com/news/world-
australia-56163550#:~:text=Australia%20has%20passed%20a%20world,to%20Australians%20over%20the%20row.">mandatory payouts from Facebook to publishers</a> — a set of rules Facebook absolutely hates but has had to <a href="https://www.nytimes.com/2021/03/16/business/media/news-corp-facebook-news.html">grudgingly accept</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="C44l4q">
So telling creators — even those Facebook would really like on the platform — that they can have a piece of the entire Facebook pie — instead of a slice of a slice — doesn’t seem like it’s going to happen.
</p></li>
<li><strong>Racist trolls attacked England’s soccer team. Fans fought back.</strong> -
<figure>
<img alt="" src="https://cdn.vox-
cdn.com/thumbor/v90oa0vJPPgwrWAueGR1WPf3Dhw=/576x0:5184x3456/1310x983/cdn.vox-
cdn.com/uploads/chorus_image/image/69583263/1233973047.0.jpg"/>
<figcaption>
A mural of soccer player Marcus Rashford in his hometown of Withington, England, where fans left messages of support following the Euros 2020 finals loss on July 11, 2021. | Lindsey Parnaby/Anadolu Agency via Getty Images
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Facebook’s and Twitter’s sluggish reactions show how they still rely on users to combat hate speech.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="6zMJwQ">
It <a href="https://abcnews.go.com/Sports/racism-soccer-epidemic-mirrors-disturbing-trends-europe-
advocates/story?id=67850877">wasn’t exactly surprising</a> that hordes of social media trolls viciously attacked three Black players on England’s soccer team with racist comments and emojis after a <a href="https://www.washingtonpost.com/sports/2021/07/11/england-vs-italy-euro-2020-final/">historic loss</a> on Sunday, July 11. What was unexpected was how quickly even more social media users came to the defense of the players.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FymVlJ">
“I’ve been working in anti-racism for over 20 years, and I am surprised at how huge and widespread and how swift the anti-racist response was,” said Sabby Dhalu, who works at the UK nonprofit Stand Up to Racism.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FwZziM">
Tens of thousands of commenters directly combated the racist attacks by posting positive messages on the personal Facebook and Instagram pages of the three players: Marcus Rashford, Jadon Sancho, and Bukayo Saka. By Monday morning in California, supportive comments started to outnumber the negative ones on players’ recent Instagram photos.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="v49L2x">
Fans trying to counteract the hate speech on Facebook and Instagram urged fellow supporters to report offensive comments to company moderators. At the same time, they expressed frustration with these companies for their sluggish moderation of these attacks.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kWOE5x">
While Twitter and Facebook eventually took down most of the blatantly racist comments, the onus fell to everyday users on the platforms to react quickly and shut down the toxic discourse. The incident showed how regular users on social media are increasingly stepping up when social media companies don’t do enough to stop the spread of hate speech on their platforms.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ZhJPXV">
Facebook, for example, does not proactively moderate a common type of racist attack, one that was being used aggressively on Rashford, Sancho, and Saka’s accounts: comments full of monkey and banana peel emojis. Instead, Facebook relies on users to report these kinds of comments, a company spokesperson told Recode. Once users report them, Facebook’s content moderators may take the comments down if the emojis are being used inappropriately. The company also encourages users experiencing harassment to defend themselves by turning on a “hidden words” feature that can block designated words or emojis in comments on their posts.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="yhOE9c">
Many soccer fans reported these types of racist posts to the social media company where the posts appeared, and also tried to overpower the posts by sharing positive messages of their own.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="pmZuze">
One <a href="https://twitter.com/DionneGrant/status/1414357994041659400">viral tweet</a> said, “They’re colour blind when you’re winning, but can only see colour when you lose. Proud of you, Bukayo Saka, Marcus Rashford and Jadon Sancho. Still we rise.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="zAan4Q">
The 15 most shared tweets containing the three players’ names as of Monday afternoon were similarly all supportive, according to data provided to Recode by social media research organization First Draft News. The hashtag “#saynotoracism” started trending on Twitter in the UK soon after the game. A supportive message about one of the players, Rashford, saying, “Our hero, always. There is so much love for you, Marcus Rashford,” was <a href="https://www.facebook.com/manchesterunited/photos/a.411767862745/10158741553287746">one of the most shared links</a> posted by a verified account on Facebook on Tuesday within the previous 24 hours, according to Facebook-owned analytics tool Crowdtangle.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="2DqUyl">
But it takes only a relatively small group of users to successfully harass someone on social media.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="r7zdOz">
Twitter said it took down 1,000 posts in the 24 hours since the game. Facebook, which owns Instagram, declined to say how many posts the company removed, but said in a statement that it “quickly removed” an unspecified number of comments and accounts.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Xjq5aV">
Still, Facebook’s and Twitter’s responses also fell short in the eyes of many British politicians and public figures, including leaders of England’s Conservative Party such as Prime Minister Boris Johnson, who sharply criticized these companies for the vitriol on their platforms. In the past, Johnson and other members of the Conservative Party have been criticized for not supporting England’s football players when they decided to take a knee to protest racial discrimination. But this time, politicians, media outlets, and public figures across the political spectrum in England were unified in their condemnation.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Ys2s4R">
“I share the anger at appalling racist abuse of our heroic players. Social media companies need to up their game in addressing it, and, if they fail to, our new Online Safety Bill will hold them to account with fines of up to 10 percent of global revenue,” Oliver Dowden, England’s Secretary of State for Digital, Culture, Media and Sport, <a href="https://twitter.com/oliverdowden/status/1414489436608466946">tweeted</a> on Monday.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="iqX5yA">
Social media companies have long struggled to police the flow of hate speech and misinformation on their platforms.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="f0mp8C">
In this case, Twitter said it used a “combination of machine learning-based automation and human review” to identify racist comments toward players, and that it “proactively” flagged a majority of this content with its technology.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="iiugYb">
Facebook said the company “quickly removed comments and accounts directing abuse at England’s footballers” and that it will “continue to take action against those that break our rules.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="gCiBV8">
“No one should have to experience racist abuse anywhere, and we don’t want it on Instagram and Facebook,” read part of a statement sent by Facebook. “No one thing will fix this challenge overnight, but we’re committed to keeping our community safe from abuse.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="0tDoXS">
But Facebook is still relying on its users to identify much of this content.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="MyM6Rl">
“I think it’s too much to be asking someone to make a complaint, every single time,” said Dhalu. “Companies need to be setting up a filter to prevent this. It’s pretty shocking that they’re not.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="lqwAlB">
And while it would have helped deter abuse against these specific players if the platforms had chosen to proactively monitor and delete racist comments on their accounts, the issue of harassment and hate speech on social media is widespread. These companies need to enforce the rules better across the board, said Sunder Katwala, director of the UK-based multiculturalism think tank British Future.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="TzDSvx">
“I think the more fundamental point is: What is allowed and what isn’t allowed?” asked Katwala. “The [social media companies] are saying, ‘racist behavior has no place on our platform,’ but you’ve got all kinds of racist comments.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="3HcEMX">
The English soccer team situation shows that social media companies still have a long way to go before they’re actually backing up their stated commitment to barring racism on their platforms. In the meantime, it seems that do-gooder users are counterbalancing the hate. Depending on how you look at it, that’s either a hopeful sign that shows everyday people are stepping up to combat racism — or it’s a disappointing indication that powerful social media companies still aren’t doing what’s necessary to stop hate speech before it spreads on their platforms.
</p></li>
</ul>
<h1 data-aos="fade-right" id="from-the-hindu-sports">From The Hindu: Sports</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>IOC guidelines for medal ceremony | Participants to wear mask all times, no group photo on podium during Tokyo Olympics</strong> - According to the new guidelines, additional podium modules will be placed between gold and silver medallists and gold and bronze medallists to allow for social-distancing.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Viswanathan Anand starts No-Castling event with win</strong> - Former world champion Viswanathan Anand defeated Russian Grandmaster Vladimir Kramnik in the first game of their four- game match for the Sparkassen T</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>India at the Tokyo Olympics</strong> - After a long and impatient wait, the country will witness its strong and skilled contingent take part in 18 sporting events.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>2022 Winter Olympics in Beijing on track despite pandemic</strong> - While China has largely eliminated local transmission of the coronavirus, it has maintained strict quarantine regulations.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Games Opening ceremony might be attended by less than 1,000 VIPs in person: Report</strong> - U.S. first lady Jill Biden is also expected to be among the international guests for the ceremony.</p></li>
</ul>
<h1 data-aos="fade-right" id="from-the-hindu-national-news">From The Hindu: National News</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>New Excise Policy will minimise corruption, provide fair competition, Delhi Govt. tells High Court</strong> - The policy, which divides Delhi into 32 zones and leaves only 16 players eligible for the trade, is giving rise to fear of monopoly</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Pursuing course of cautious optimism amid COVID-19: CBDT Chairman Mohapatra</strong> - The department is geared up to take on the challenge of domestic resource mobilisation in these uncertain times, CBDT Chairman Jagannath Bidyadhar Mohapatra said</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>From Mizoram, limbless amphibian added to India’s fauna</strong> - Ichthyophis multicolor recorded in Mizoram seven years after the species was first recorded more than 800 km away in the Ayeyarwady region of Myanmar</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Army opens fire after Pak quadcopter spotted along LoC in Jammu</strong> - The Army fired on a Pakistani quadcopter after it tried to venture into the Indian territory along the Line of Control (LoC) here, official sources s</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Wanted Naxal killed by security forces in Jharkhand</strong> - A 45-year-old Maoist carrying a reward of ₹ 15 lakh has been killed by security forces in the jungles of Jharkhand’s Gumla district on Thursday, offi</p></li>
</ul>
<h1 data-aos="fade-right" id="from-bbc-europe">From BBC: Europe</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Germany floods: At least 33 dead and dozens missing after record rain</strong> - Dozens more are missing after some of the worst flooding in years struck the west of the country.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>More flooding for Europe</strong> - There is more rain to come from the storm that brought Wednesday’s deadly flooding</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Australia attacks sweeping EU climate plan to tax imports</strong> - Australia, a fossil fuel exporting giant, says the EU’s plan to impose carbon trade fees is “protectionist”.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Czech women seek compensation for coerced sterilisations</strong> - Thousands of women were sterilised without their consent in former Czechoslovakia in the 1970s and 1980s.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Euro 2020: Four people arrested over racist abuse of England players</strong> - Players who missed penalties were targeted online after the team lost the Euro 2020 final.</p></li>
</ul>
<h1 data-aos="fade-right" id="from-ars-technica">From Ars Technica</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>James Bond’s new car is a plug-in hybrid—the Aston Martin Valhalla</strong> - It has 937 horsepower from a pair of electric motors and a twin-turbo V8. - <a href="https://arstechnica.com/?p=1780489">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Netflix will start publishing video games, has hired former EA exec</strong> - Follows years-long tiptoe into interactive specials, game-based TV series. - <a href="https://arstechnica.com/?p=1780447">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Unvaccinated health workers are “unethical and appalling”—experts want mandates</strong> - Health organizations call for mandatory COVID-19 vaccination for health care workers. - <a href="https://arstechnica.com/?p=1780441">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>After defeating Hernando de Soto, the Chickasaw took his stuff and remade it</strong> - The site offers rare evidence of interactions between de Soto and Indigenous people. - <a href="https://arstechnica.com/?p=1780081">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>With Apple Pay Later, Apple may take another stab at the PayPal model</strong> - Apple plans to offer iPhone users another way to borrow money. - <a href="https://arstechnica.com/?p=1780202">link</a></p></li>
</ul>
<h1 data-aos="fade-right" id="from-jokes-subreddit">From Jokes Subreddit</h1>
<ul>
<li><strong>A teenage immigrant boy comes home from school.</strong> - <!-- SC_OFF -->
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
His mother asks him “How were your classes today?”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Today we had sex education mama”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Shocked his mother replies. “What?! You go to your room and wait till your father comes home. He’s going to have stern words with you.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
When the father comes home and learns about his sons class he replies. “This isn’t the old country, people are more liberal here, don’t worry. This should be good for him.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Feeling bad she goes upstairs to apologise and finds him vigorously masturbating.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The mother says. “Luigi, when you finish your homework I want to have a word with you.”
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/daftwordhero"> /u/daftwordhero </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/oknbn6/a_teenage_immigrant_boy_comes_home_from_school/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/oknbn6/a_teenage_immigrant_boy_comes_home_from_school/">[comments]</a></span></p></li>
<li><strong>A Scientologist, a Catholic, and a Mormon are talking about their families.</strong> - <!-- SC_OFF -->
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The Scientologist jokes, “I’ve got 4 kids. One more and I’ll have a basketball team!” The Catholic joins in and says, “Well I’ve got 10 kids, and one more I’ll have a football team!”. The Mormon speaks up and deadpans. “I’ve got 17 wives. One more and I’ll have a golf course.”
</p>
</div>
<!--
SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/Dawgpile615"> /u/Dawgpile615 </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/okjo0z/a_scientologist_a_catholic_and_a_mormon_are/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/okjo0z/a_scientologist_a_catholic_and_a_mormon_are/">[comments]</a></span></p></li>
<li><strong>Monkey Who Does Great Sex</strong> - <!-- SC_OFF -->
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
A young sexy woman passing by a pet shop saw a board -
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Monkey who does great sex”.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
She went in, bought that monkey &amp; walked away with the Instruction Manual.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The Manual said <em>‘Give a good bath to the monkey, then you take a bath. Make him sit on the bed and you lie down without wearing anything. Leave the rest to the monkey. Repeat all steps for repeat performance’</em>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Accordingly, the woman gave the monkey a bath, bathed herself and slept on the bed naked.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
<em>Monkey did nothing</em>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Disappointed, she again gave him a bath, had bath and lay down naked on the bed.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
<em>Again, the monkey did nothing</em>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
She referred the Manual to check for forward path. It said : <em>‘In case of no activity, call the shop owner for support’</em>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
She called the owner &amp; he arrived in 10 minutes. He asked the woman to lie down. He then smiled at the monkey and shouted…
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
<em>“I’m teaching you for the last time, watch carefully!!!!!!” </em>
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/swapniljadav"> /u/swapniljadav </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/okli6l/monkey_who_does_great_sex/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/okli6l/monkey_who_does_great_sex/">[comments]</a></span></p></li>
<li><strong>I told my girlfriend that the milkman said he had shagged every woman in our building except one!!</strong> - <!-- SC_OFF -->
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“I bet it’s the snooty bitch at number twenty three,” she replied.
</p>
</div>
<!--
SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/littleboy_xxxx"> /u/littleboy_xxxx </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/ok6qpz/i_told_my_girlfriend_that_the_milkman_said_he_had/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/ok6qpz/i_told_my_girlfriend_that_the_milkman_said_he_had/">[comments]</a></span></p></li>
<li><strong>A middle aged man was talking to his elderly father</strong> - <!-- SC_OFF -->
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“I wanted to thank you dad, I remember when I was younger and first dating girls you gave me a piece of advice. You said ‘good companion, good in bed, good mother - pick two’”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The father looked kindly at his son and nodded.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Well, I feel like I have a good life. My wife is kind to me and a lovely mother to our three kids.” The father nodded back to his son with a knowing look and replied.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“That’s great son, but when I said ‘pick two’ I meant pick the second one.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
EDIT: credit to a likely source. <a href="https://www.smbc-comics.com/comic/2012-03-17">https://www.smbc-comics.com/comic/2012-03-17</a>
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/Snuffleupagus03"> /u/Snuffleupagus03 </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/ok8zst/a_middle_aged_man_was_talking_to_his_elderly/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/ok8zst/a_middle_aged_man_was_talking_to_his_elderly/">[comments]</a></span></p></li>
</ul>
<script>AOS.init();</script></body></html>

4
index.html
View File

File diff suppressed because one or more lines are too long